+499.5%
MRNA vs RRC
+23.4%
+476.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RRC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.9% | -1.4% | -1.9% |
| 7D | +5.5% | +1.3% | +4.2% | +5.1% |
| 30D | +158.7% | +10.1% | +148.6% | +152.6% |
| 3M | +182.1% | +4.0% | +178.1% | +178.2% |
| 6M | +151.8% | +1.6% | +150.2% | +147.0% |
| YTD | +393.6% | +19.7% | +373.8% | +354.8% |
| 1Y | +499.5% | +21.4% | +478.0% | +461.2% |
| All | +499.5% | +23.4% | +476.1% | +461.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RRC.
Daily Out/Under-Performance
Portfolio return minus RRC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RRC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RRC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling